Clinical effects of gonadotropin-releasing hormone analogue in metastatic carcinoma of prostate
Authors:
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Effect of very high dose D-leucine6-gonadotropin-releasing hormone proethylamide on the hypothalamic-pituitary testicular axis in patients with prostatic cancer.Journal of Clinical Investigation, 1983
- Treatment of newly diagnosed metastatic prostate cancer patients with chemotherapy agents in combination with hormones versus hormones aloneCancer, 1983
- Comparison of Estramustine Phosphate and Vincristine Alone or in Combination for Patients with Advanced, Hormone Refractory, Previously Irradiated Carcinoma of the ProstateJournal of Urology, 1981
- The importance of the stable category for chemotherapy treated patients with advanced and relapsing prostate cancerCancer, 1980
- Chronic Effects of [D-Trp6,Pro9-NEt]Luteinizing Hormone-Releasing Factor on Reproductive Processes in the Male Rat*Endocrinology, 1979
- Prostatic CarcinomaNew England Journal of Medicine, 1979
- An Experimental Approach to the Optimum Oestrogen Dosage in Prostatic CarcinomaBritish Journal of Urology, 1978
- Chemotherapy of advanced prostatic cancer Evaluation of response parametersUrology, 1976
- The natural history of prostatic cancerCancer, 1973
- Prevention of Gynecomastia by Local Roentgen Irradiation in Estrogen-Treated Prostatic CarcinomaScandinavian Journal of Urology and Nephrology, 1969